BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10392)

  • 1. The microsomal N-oxidation of phentermine.
    Beckett AH; Bélanger PM
    J Pharm Pharmacol; 1976 Sep; 28(9):692-9. PubMed ID: 10392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of microsomal enzyme systems that reduce N-hydroxyphentermine.
    Sum CY; Cho AK
    Drug Metab Dispos; 1976; 4(5):436-41. PubMed ID: 10142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-oxidation of phentermine to N-hydroxyphentermine by a reconstituted cytochrome P-450 oxidase system from rabbit liver.
    Duncan JD; Cho AK
    Mol Pharmacol; 1982 Sep; 22(2):235-8. PubMed ID: 6815477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of superoxide in the N-oxidation of N-(2-methyl-1-phenyl-2-propyl)hydroxylamine by the rat liver cytochrome P-450 system.
    Duncan JD; Di Stefano EW; Miwa GT; Cho AK
    Biochemistry; 1985 Jul; 24(15):4155-61. PubMed ID: 2996591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification and analysis of the metabolic products of mephentermine.
    Beckett AH; Bélanger PM
    J Pharm Pharmacol; 1975 Dec; 27(12):928-36. PubMed ID: 2665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of N-hydroxyphentermine by rat liver microsomes.
    Sum CY; Cho AK
    Drug Metab Dispos; 1979; 7(2):65-9. PubMed ID: 38075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of oxidation of N-hydroxyphentermine by superoxide.
    Fukuto JM; Di Stefano EW; Burstyn JN; Valentine JS; Cho AK
    Biochemistry; 1985 Jul; 24(15):4161-7. PubMed ID: 2996592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of N-hydroxyphentermine to 2-methyl-2-nitro-1-phenylpropane by liver microsomes.
    Maynard MS; Cho AK
    Biochem Pharmacol; 1981 May; 30(10):1115-9. PubMed ID: 6894858
    [No Abstract]   [Full Text] [Related]  

  • 9. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of hepatic microsomal N-oxide formation. N-oxidation of NN-dimethylaniline by a reconstituted rabbit liver microsomal cytochrome P-448 enzyme system.
    Hlavica P; Hülsmann S
    Biochem J; 1979 Jul; 182(1):109-16. PubMed ID: 115464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of three new metabolic products of phentermine after liver microsomal incubation.
    Beckett AH; Bélanger PM
    Xenobiotica; 1974 Aug; 4(8):509-19. PubMed ID: 4421114
    [No Abstract]   [Full Text] [Related]  

  • 12. Microsomal N-hydroxylation of dibenzylamine.
    Beckett AH; Gibson GG
    Xenobiotica; 1975 Nov; 5(11):677-86. PubMed ID: 1189462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene.
    Kadlubar FF; Miller JA; Miller EC
    Cancer Res; 1976 Mar; 36(3):1196-1206. PubMed ID: 814998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidation of N-hydroxyphentermine by various oxidase systems.
    Maynard MS; Cho AK
    Proc West Pharmacol Soc; 1979; 22():105-7. PubMed ID: 229486
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of the suicidal, reductive inactivation of microsomal cytochrome P-450 by carbon tetrachloride.
    Manno M; De Matteis F; King LJ
    Biochem Pharmacol; 1988 May; 37(10):1981-90. PubMed ID: 3377806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450.
    Di Augustine RP; Fouts JR
    Biochem J; 1969 Nov; 115(3):547-54. PubMed ID: 4390924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
    Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
    Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of phentermine and its N-oxidized metabolic products in the rabbit.
    Beckett AH; Belanger PM
    Xenobiotica; 1978 Jan; 8(1):55-60. PubMed ID: 24306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some factors involved in the N-oxidation of 3-substituted pyridines by microsomal preparations in vitro.
    Gorrod JW; Damani LA
    Xenobiotica; 1979 Apr; 9(4):209-18. PubMed ID: 483857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.